Evidence map›Paper›PMID 41800151›Full record

ArticleDigital health

Generating subjective, objective, assessment, and plan (SOAP)-structured medication logs using DeepSeek-R1 through prompt engineering and multi-source clinical information.

Yuxuan Zhu, Jizhong Zhang, Yuhao Sun, Jiayu Wen, Zhixian Liu, Xin Liu, Silu Xu, Nan Wu, Yuanyuan Zhang, Guoren Zhou and 1 more

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yuxuan ZhuJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.ORCID https://orcid.org/0009-0008-3591-0561
Jizhong ZhangJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Yuhao SunJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Jiayu WenJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Zhixian LiuJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Xin LiuJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Silu XuJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Nan WuJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Yuanyuan ZhangJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Guoren ZhouJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.
Jifu WeiJiangsu Cancer Hospital, The Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Institute of Cancer Research, Jiangsu Key Laboratory of Innovative Cancer Diagnosis & Therapeutics, Nanjing, Jiangsu Province, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objectives: This study evaluated the feasibility of using the open-source large language model (LLM) DeepSeek-R1 to generate standardized Subjective, Objective, Assessment, and Plan (SOAP)-format medication logs and its potential to support clinical pharmacists. Materials and methods: Thirty complete oncology medication profiles were collected, from which 80 days of logs were extracted and converted into simulated pharmacist-patient dialogues. The experiment compared single-information-source inputs (dialogue only) with multi-information-source inputs (dialogue plus patient information, records, and test results), using five prompts of increasing complexity. Performance was measured using the Bidirectional Encoder Representations from Transformers (BERT) score and Recall-Oriented Understudy for Gisting Evaluation (ROUGE), alongside a blinded expert evaluation based on the Seven-Dimension Index (7DI) metric. Results: DeepSeek-R1 effectively generated structured SOAP medication logs when integrated with multi-source information and complex prompts (especially Prompts 4 and 5). Both machine scores and manual 7DI evaluation confirmed the superiority of multi-source inputs over single-source dialogues. While Prompt 4 achieved the highest BERT- Discussion: This study confirms DeepSeek-R1's utility in generating SOAP medication logs using multi-source data and structured prompts, potentially enhancing pharmacists' efficiency. Limitations such as oncology-specific scope and artificial intelligence (AI) hallucinations necessitate pharmacist review and future validation across specialties, alongside comparisons with closed-source LLMs and explainable AI integration. Conclusion: This study demonstrates that DeepSeek-R1 can generate structured SOAP-format medication logs when guided by prompt-engineered multi-source clinical information, while highlighting that output quality depends on input completeness and that pharmacist review remains essential for clinical reliability.

Indexed as

clinical pharmacy information systemsdrug therapylarge language modelmedical records systems, computerizedNatural language processing

Identifiers

PMID41800151
PMCPMC12966567

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.